Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists

被引：17
|
作者：
Kant, Sam [1 ]
Kronbichler, Andreas [2 ]
Salas, Antonio [1 ]
Bruchfeld, Annette [3 ,4 ]
Geetha, Duvuru [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA
[2] Med Univ Innsbruck, Dept Internal Med Nephrol & Hypertens 4, Innsbruck, Austria
[3] Karolinska Univ Hosp, Dept Renal Med, Stockholm, Sweden
[4] CLINTEC Karolinska Inst, Stockholm, Sweden
来源：
KIDNEY INTERNATIONAL REPORTS | 2021年 / 6卷 / 05期
关键词：
anti-CD20; COVID-19; vaccine;
D O I：
10.1016/j.ekir.2021.03.876
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1197 / 1199
页数：3
相关论文
共 50 条
  • [31] COVID-19 infection in patients on anti-CD20 monoclonal antibodies: Changes in clinical outcomes and management over time
    Ali, Mohammad
    Abdullah, Hafez M.
    Ahmed, Mamoon
    Chaudhry, Hammad
    Khan, Dawlat
    Khalil, Fouad
    Wachira, David
    Bleeker, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
    Nishikubo, Masashi
    Shimomura, Yoshimitsu
    Yamamoto, Ryusuke
    Yoshioka, Satoshi
    Maruoka, Hayato
    Nasu, Seiko
    Nishioka, Tomomi
    Sakizono, Kenji
    Mitsuyuki, Satoshi
    Kubo, Tomoyo
    Okada, Naoki
    Nakagawa, Daishi
    Kamijo, Kimimori
    Imoto, Hiroharu
    Nagai, Yuya
    Hiramoto, Nobuhiro
    Yonetani, Noboru
    Kondo, Tadakazu
    Miyakoshi, Chisato
    Doi, Asako
    Ishikawa, Takayuki
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [33] Sotrovimab Treatment for COVID-19 Effective in a B-Cell-Depleted Patient After Anti-CD20 Treatment
    Murase, Kazuyuki
    Takada, Kohichi
    Arihara, Yohei
    Miyanishi, Koji
    Kato, Junji
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [34] Booster Dose of mRNA-Based COVID-19 Vaccine Induces a Humoral and Cellular Response in Patients Recently Treated with Anti-CD20 Monoclonal Antibodies
    Nishikubo, Masashi
    Shimomura, Yoshimitsu
    Yamamoto, Ryusuke
    Maruoka, Hayato
    Nasu, Seiko
    Nishioka, Tomomi
    Sakizono, Kenji
    Mitsuyuki, Satoshi
    Kubo, Tomoyo
    Okada, Naoki
    Nakagawa, Daishi
    Kamijo, Kimimori
    Imoto, Hiroharu
    Nagai, Yuya
    Hiramoto, Nobuhiro
    Yoshioka, Satoshi
    Yonetani, Noboru
    Kondo, Tadakazu
    Ishikawa, Takayuki
    BLOOD, 2022, 140 : 2633 - 2634
  • [35] Sequential cellular and humoral responses after repetitive COVID-19 vaccination in patients treated with anti-CD20 antibodies
    Nishikubo, Masashi
    Shimomura, Yoshimitsu
    Yamamoto, Ryusuke
    Maruoka, Hayato
    Nasu, Seiko
    Sakizono, Kenji
    Nagai, Yuya
    Hiramoto, Nobuhiro
    Yonetani, Noboru
    Kondo, Tadakazu
    Miyakoshi, Chisato
    Doi, Asako
    Ishikawa, Takayuki
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (03) : 821 - 825
  • [36] Timing of anti-viral therapy in COVID-19: key to success
    Madan, Manu
    Mohan, Anant
    Madan, Karan
    Hadda, Vijay
    Tiwari, Awan
    Guleria, Randeep
    Mittal, Saurabh
    ADVANCES IN RESPIRATORY MEDICINE, 2021, 89 (02) : 237 - 239
  • [37] Anti-CD20 treatments and the lymphocyte membrane: Pathology for therapy
    Borisch, B
    Semac, I
    Soltermann, A
    Palomba, C
    Hoessli, DC
    VERHANDLUNGEN DER DEUTSCHEN GESELLSCHAFT FUR PATHOLOGIE 85. TAGUNG: PATHOLOGIE FUR DAS 21. JAHRHUNDERT, 2001, 85 : 161 - 166
  • [38] Should anti-CD20 be used as an immune reconstitution therapy?
    Smets, Ide
    Wokke, Beatrijs
    Smolders, Joost
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (02) : 308 - 310
  • [39] What signals are generated by anti-CD20 antibody therapy?
    Bonavida B.
    Current Hematologic Malignancy Reports, 2006, 1 (4) : 205 - 213
  • [40] Anti-CD20 therapy in pregnancy: Balancing risks and benefits
    Thiel, Sandra
    Hellwig, Kerstin
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (02) : 274 - 275
12345